Oh Tae-Ju, Meraw Stephen J, Lee Eun-Ju, Giannobile William V, Wang Hom-Lay
Department of Periodontics/Prevention/Geriatrics, University of Michigan School of Dentistry, Ann Arbor, MI, USA.
Clin Oral Implants Res. 2003 Feb;14(1):80-90. doi: 10.1034/j.1600-0501.2003.140111.x.
Guided bone regeneration (GBR) evolved from the concept of guided tissue regeneration (GTR) and has been used for reconstructing sites with bone deficiencies associated with dental implants. For GBR, the use of absorbable collagen membranes has been increasing, but, at present, scientific information on the use of collagen membranes for GBR is limited. This study was aimed to clinically and histomorphometrically compare two collagen membranes, Bio-Gide(R) and BioMend ExtendTM, for the treatment of implant dehiscence defects in eight mongrel dogs. Implant dehiscence defects were surgically created in edentulous ridges, followed by the placement of three endosseous implants bilaterally in the mandible. Each implant dehiscence defect was randomly assigned to one of three treatment groups: (1) control (no membrane), (2) porcine dermis collagen barrier (Bio-Gide) or (3) bovine tendon collagen barrier (BioMend Extend). Dogs were sacrificed at 4 and 16 weeks (four dogs each) after treatment. Histomorphometric analysis included percentage linear bone fill (LF), new bone-to-implant contact (BIC) and area of new bone fill (BF). The results of the study revealed no significant differences among groups for any parameter at 4 weeks. However, at 16 weeks, more LF, BIC, and BF were noted in the membrane-treated groups than controls. BioMend Extend-treated defects demonstrated significantly greater BIC than control (P < 0.05) at this time point. BIC at 16 weeks was significantly greater than 4-week BIC (P < 0.05). Membrane exposure occurred in 9 out of 15 sites examined, resulting in significantly less LF and BIC than the sites without membrane exposure (P < 0.05). The results of this study indicate that: (1) GBR treatment with collagen membranes may significantly enhance bone regeneration, manifested at late stage (16 weeks) of healing; and (2) space maintenance and membrane coverage were the two most important factors affecting GBR using bioabsorbable collagen membranes.
引导骨再生(GBR)由引导组织再生(GTR)的概念发展而来,已被用于重建与牙种植体相关的骨缺损部位。对于GBR,可吸收胶原膜的使用一直在增加,但目前关于胶原膜用于GBR的科学信息有限。本研究旨在通过临床和组织形态计量学比较两种胶原膜Bio-Gide®和BioMend ExtendTM治疗8只杂种犬种植体裂开缺陷的效果。在无牙颌牙槽嵴上手术制造种植体裂开缺陷,然后在下颌双侧植入3枚骨内种植体。每个种植体裂开缺陷随机分为三个治疗组之一:(1)对照组(不使用膜)、(2)猪真皮胶原屏障(Bio-Gide)或(3)牛肌腱胶原屏障(BioMend Extend)。治疗后4周和16周处死犬(各4只)。组织形态计量学分析包括线性骨填充百分比(LF)、新骨与种植体接触(BIC)和新骨填充面积(BF)。研究结果显示,4周时各参数组间无显著差异。然而,在16周时,膜治疗组的LF、BIC和BF均高于对照组。此时,BioMend Extend治疗的缺损部位BIC显著高于对照组(P < 0.05)。16周时的BIC显著高于4周时的BIC(P < 0.05)。在检查的15个部位中有9个发生了膜暴露,导致LF和BIC显著低于未发生膜暴露的部位(P < 0.05)。本研究结果表明:(1)使用胶原膜进行GBR治疗可显著促进骨再生,在愈合后期(16周)表现明显;(2)空间维持和膜覆盖是影响使用可吸收胶原膜进行GBR的两个最重要因素。